Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
Clinical trial NCT03603106 · COMPLETED
Trial details
- NCT number
- NCT03603106
- Sponsor
- Guerbet
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-25
- Primary completion
- 2015-04-17
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.